Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation

Ashutosh Agarwal, Marija Balic, Dorraya El-Ashry, Richard J Cote

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases, which are ultimately responsible for most cancer deaths. Technologies that allow for identification and enumeration of rare CTC from cancer patients' blood have already established CTC as an important clinical biomarker for cancer diagnosis and prognosis. Indeed, current efforts to robustly characterize CTC as well as the associated cells of the tumor microenvironment such as circulating cancer associated fibroblasts (cCAF), are poised to unmask key insights into the metastatic process. Ultimately, the clinical utility of CTC will be fully realized once CTC can be reliably cultured and proliferated as a biospecimen for precision management of cancer patients, and for discovery of novel therapeutics. In this review, we highlight the latest CTC capture and analyses technologies, and discuss in vitro strategies for culturing and propagating CTC.

Original languageEnglish (US)
Pages (from-to)70-77
Number of pages8
JournalCancer Journal (United States)
Volume24
Issue number2
DOIs
StatePublished - Mar 1 2018

Fingerprint

Circulating Neoplastic Cells
Neoplasms
Technology
Cellular Microenvironment
Tumor Microenvironment
Tumor Biomarkers
Neoplasm Metastasis

Keywords

  • cCAF
  • Circulating tumor cells
  • clinical biomarkers
  • CTC

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Circulating Tumor Cells : Strategies for Capture, Analyses, and Propagation. / Agarwal, Ashutosh; Balic, Marija; El-Ashry, Dorraya; Cote, Richard J.

In: Cancer Journal (United States), Vol. 24, No. 2, 01.03.2018, p. 70-77.

Research output: Contribution to journalReview article

@article{e177694bc83049d79d8653793b056faa,
title = "Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation",
abstract = "Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases, which are ultimately responsible for most cancer deaths. Technologies that allow for identification and enumeration of rare CTC from cancer patients' blood have already established CTC as an important clinical biomarker for cancer diagnosis and prognosis. Indeed, current efforts to robustly characterize CTC as well as the associated cells of the tumor microenvironment such as circulating cancer associated fibroblasts (cCAF), are poised to unmask key insights into the metastatic process. Ultimately, the clinical utility of CTC will be fully realized once CTC can be reliably cultured and proliferated as a biospecimen for precision management of cancer patients, and for discovery of novel therapeutics. In this review, we highlight the latest CTC capture and analyses technologies, and discuss in vitro strategies for culturing and propagating CTC.",
keywords = "cCAF, Circulating tumor cells, clinical biomarkers, CTC",
author = "Ashutosh Agarwal and Marija Balic and Dorraya El-Ashry and Cote, {Richard J}",
year = "2018",
month = "3",
day = "1",
doi = "10.1097/PPO.0000000000000310",
language = "English (US)",
volume = "24",
pages = "70--77",
journal = "Cancer journal (Sudbury, Mass.)",
issn = "1528-9117",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "2",

}

TY - JOUR

T1 - Circulating Tumor Cells

T2 - Strategies for Capture, Analyses, and Propagation

AU - Agarwal, Ashutosh

AU - Balic, Marija

AU - El-Ashry, Dorraya

AU - Cote, Richard J

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases, which are ultimately responsible for most cancer deaths. Technologies that allow for identification and enumeration of rare CTC from cancer patients' blood have already established CTC as an important clinical biomarker for cancer diagnosis and prognosis. Indeed, current efforts to robustly characterize CTC as well as the associated cells of the tumor microenvironment such as circulating cancer associated fibroblasts (cCAF), are poised to unmask key insights into the metastatic process. Ultimately, the clinical utility of CTC will be fully realized once CTC can be reliably cultured and proliferated as a biospecimen for precision management of cancer patients, and for discovery of novel therapeutics. In this review, we highlight the latest CTC capture and analyses technologies, and discuss in vitro strategies for culturing and propagating CTC.

AB - Circulating tumor cells (CTCs) play a central role in tumor dissemination and metastases, which are ultimately responsible for most cancer deaths. Technologies that allow for identification and enumeration of rare CTC from cancer patients' blood have already established CTC as an important clinical biomarker for cancer diagnosis and prognosis. Indeed, current efforts to robustly characterize CTC as well as the associated cells of the tumor microenvironment such as circulating cancer associated fibroblasts (cCAF), are poised to unmask key insights into the metastatic process. Ultimately, the clinical utility of CTC will be fully realized once CTC can be reliably cultured and proliferated as a biospecimen for precision management of cancer patients, and for discovery of novel therapeutics. In this review, we highlight the latest CTC capture and analyses technologies, and discuss in vitro strategies for culturing and propagating CTC.

KW - cCAF

KW - Circulating tumor cells

KW - clinical biomarkers

KW - CTC

UR - http://www.scopus.com/inward/record.url?scp=85044923289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044923289&partnerID=8YFLogxK

U2 - 10.1097/PPO.0000000000000310

DO - 10.1097/PPO.0000000000000310

M3 - Review article

C2 - 29601333

AN - SCOPUS:85044923289

VL - 24

SP - 70

EP - 77

JO - Cancer journal (Sudbury, Mass.)

JF - Cancer journal (Sudbury, Mass.)

SN - 1528-9117

IS - 2

ER -